account$3.1) in the morning trading session. Related readings: A Hong Kong-based subsidiary of Fosun Pharma, a leading Chinese pharmaceutical company, paid $22 million for 11.18 percent stake in Chindex International Inc, a US-based medical services and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Fosun Pharma rises on acquisition deal
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account